Project Grant HT94252410859
Award Date
9/1/24
Completion Date
8/31/26
Dollars Obligated
$297K
Federal Agency
Defense Health Agency
Federal Grant Program
12.420
Assistance Type
Project Grant
Place of Performance
Birmingham, AL 35294, USA
Similar Awards
The University of Alabama at Birmingham (UAB) was awarded a $733,662 Project Grant from the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420). The grant, awarded on September 1, 2024, supports research to investigate the role of tumor glycans in immune suppression. This federally funded project aims to advance scientific understanding of how specific carbohydrate molecules on tumor cells can inhibit the body's immune response, with the goal of...
The University of Alabama at Birmingham (UAB) has been awarded a $297,000 Project Grant from the Department of Defense's Defense Health Agency under the Military Medical Research and Development (CFDA 12.420) program. This grant, awarded on August 1, 2024, will fund research to evaluate the role of Notch signaling in chronic pancreatitis. As a leading research institution, UAB will leverage its expertise in biomedical research to advance scientific understanding and potentially improve treatment...
The University of Alabama at Birmingham (UAB) was awarded a $2,119,086 Project Grant by the Defense Health Agency (DHA) under the Department of Defense's Military Medical Research and Development program (CFDA 12.420) to conduct research on the Hedgehog pathway in chronic pancreatitis. The 4-year grant, which began on September 30, 2023, aims to advance scientific understanding and develop new therapeutic approaches for this health condition affecting military service members and veterans....
This federal Project Grant award from the Defense Health Agency under the Military Medical Research and Development (CFDA 12.420) program provides $1,485,001.00 to the University of Alabama at Birmingham (UAB) to conduct research on "Overcoming Perturbations that Orchestrate Immune Exhaustion and Dysfunction in Breast Cancer." The research aims to transform healthcare for military service members, veterans, and the broader public by investigating innovative medical solutions to address...
The University of Alabama at Birmingham (UAB) was awarded a $907,805 Project Grant from the Department of the Army Medical Command under the Military Medical Research and Development program (CFDA 12.420). The three-year award beginning April 15, 2022 will support research entitled "Elevated Uracil Glycosylase Coupled to Reduced Base Excision Repair Promotes AA PCA Progression." Per the grant details, UAB will investigate how specific DNA repair mechanisms may promote the progression...
This Project Grant award of $1,113,750.00 from the Defense Health Agency, under the Military Medical Research and Development program (CFDA 12.420), supports the University of Alabama at Birmingham (UAB) in developing "DUAL CD24/CD276 TARGETING THERAPIES FOR TRIPLE-NEGATIVE BREAST CANCER." The 3-year award, running from August 1, 2023 to July 31, 2026, will fund research to investigate medical solutions for the battlefield and transform health care for service members and the public...
This Project Grant award of $650,845, awarded by the Defense Health Agency under the Military Medical Research and Development (CFDA 12.420) program, supports advanced biomedical research at the University of Alabama at Birmingham (UAB) focused on developing macrophage-centric prognostic biomarkers for checkpoint blockade immunotherapy in melanoma. The research aims to transform healthcare for military service members, veterans, and the broader public by investigating innovative medical...
This Project Grant award from the Defense Health Agency's Military Medical Research and Development program (CFDA 12.420) provides $227,167 to the University of Alabama at Birmingham (UAB) to conduct research on "Macrophage-Centric Prognostic Biomarkers for Checkpoint Blockade Immunotherapy in Melanoma." The award period runs from July 1, 2025 to June 30, 2028. UAB, a prominent public research university known for its biomedical research capabilities, will leverage its expertise to...
This federal Project Grant award of $1,317,584.00 from the Defense Health Agency's Military Medical Research and Development program (CFDA 12.420) supports advanced biomedical research at the University of Alabama at Birmingham (UAB) aimed at developing macrophage-centric prognostic biomarkers for checkpoint blockade immunotherapy in melanoma. The 3-year project, which commenced on July 1, 2025, leverages UAB's extensive biomedical research capabilities and expertise in areas such as cancer,...
This Project Grant award, valued at $723,456.00, was provided by the Defense Health Agency under the Military Medical Research and Development (CFDA 12.420) program. The grant supports advanced biomedical research at the University of Alabama at Birmingham (UAB) aimed at investigating the role of parkin-mediated mitophagy in susceptibility and resilience to mitochondrial toxicant exposures. The 3-year award, running from September 1, 2025 to August 31, 2028, will enable UAB to conduct...